v3.25.1
Condensed Consolidated Interim Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2025
Sep. 30, 2024
Current    
Cash and cash equivalents $ 115,771 $ 132,187
Incentive and tax receivables 666 2,449
Prepaid expenses and other current assets 702 931
Total Assets 117,139 135,567
Current Liabilities    
Accounts payable 6,997 9,627
Accrued liabilities - Note 3 9,555 4,835
Deferred grant income - Note 4 829 842
Total Liabilities 17,381 15,304
Capital stock Authorized:10,000,000 preferred stock, par value $0.001 per share
Capital stock Authorized:200,000,000 common stock, par value $0.001 per share 84,985,449 common shares (September 30, 2024 - 84,795,517) 85 85
Additional paid-in capital 459,051 456,249
Accumulated deficit (359,378) (336,071)
Total Stockholders’ Equity 99,758 120,263
Total Liabilities and Stockholders’ Equity $ 117,139 $ 135,567